1. Home
  2. TVTX vs HTH Comparison

TVTX vs HTH Comparison

Compare TVTX & HTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • HTH
  • Stock Information
  • Founded
  • TVTX 2008
  • HTH 1998
  • Country
  • TVTX United States
  • HTH United States
  • Employees
  • TVTX N/A
  • HTH N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • HTH Major Banks
  • Sector
  • TVTX Health Care
  • HTH Finance
  • Exchange
  • TVTX Nasdaq
  • HTH Nasdaq
  • Market Cap
  • TVTX 1.8B
  • HTH 1.8B
  • IPO Year
  • TVTX N/A
  • HTH 2004
  • Fundamental
  • Price
  • TVTX $21.98
  • HTH $31.17
  • Analyst Decision
  • TVTX Strong Buy
  • HTH Hold
  • Analyst Count
  • TVTX 12
  • HTH 2
  • Target Price
  • TVTX $30.08
  • HTH $34.00
  • AVG Volume (30 Days)
  • TVTX 1.8M
  • HTH 459.6K
  • Earning Date
  • TVTX 02-20-2025
  • HTH 04-17-2025
  • Dividend Yield
  • TVTX N/A
  • HTH 2.29%
  • EPS Growth
  • TVTX N/A
  • HTH 3.22
  • EPS
  • TVTX N/A
  • HTH 1.74
  • Revenue
  • TVTX $233,175,000.00
  • HTH $1,187,813,000.00
  • Revenue This Year
  • TVTX $62.88
  • HTH N/A
  • Revenue Next Year
  • TVTX $57.60
  • HTH $3.56
  • P/E Ratio
  • TVTX N/A
  • HTH $18.04
  • Revenue Growth
  • TVTX 60.55
  • HTH 0.88
  • 52 Week Low
  • TVTX $5.12
  • HTH $26.67
  • 52 Week High
  • TVTX $25.29
  • HTH $35.32
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 53.52
  • HTH 53.58
  • Support Level
  • TVTX $22.48
  • HTH $31.40
  • Resistance Level
  • TVTX $23.69
  • HTH $32.24
  • Average True Range (ATR)
  • TVTX 1.22
  • HTH 0.78
  • MACD
  • TVTX -0.02
  • HTH -0.05
  • Stochastic Oscillator
  • TVTX 41.10
  • HTH 50.83

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.

About HTH Hilltop Holdings Inc.

Hilltop Holdings Inc is a Dallas-based financial holding company. Its primary line of business is to provide business and consumer banking services from offices throughout Texas through the PlainsCapital Bank. The company also provides other financial products and services through its broker-dealer and mortgage origination segments. The company generates a majority of its revenue through its banking operations.

Share on Social Networks: